Orphan Drugs Market

Global Orphan Drugs Market, By Drug Type (Biological and Non- Biological), By Top Selling Drugs (Revlimid, Rituxan, Copaxone, Opdivo, Keytruda, Imbruvica, Avonex, Sensipar, Soliris, and Other Top Selling Drugs), By Disease Type (Oncology, Hematology, Neurology, Cardiovascular, and Other Disease Types), By Phase (Phase I, Phase II, Phase III, and Phase IV), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

PMI379319 | Pharmaceutical

Dec 2019 | 162 | PDF

Introduction:

Orphan drugs are the pharmaceutical mediators which are developed to treat rare medical conditions. Orphan drugs would not be able to earn profit because the orphan drugs are used to treat the rare diseases. It can only produce profit by the involvement of government assistant. Orphan drugs use to diagnoses and to prevent the diseases. Orphan drugs are not developed in industry, but it is generated for the public welfare.

Drivers and Restraints:

Orphan drugs market is extensively high for orphan drug developers which is the major propelling factor for the growth of target market. In addition, the orphan drugs can treat the diseases type such as cardiology, oncology, and hematology, neurology which is the boosting factor for the growth of global market. As per the data published by WHO (World’s Health Organization), globally in 2016, cardiovascular diseases (CVD) are the main cause of death, around 17.9 million people died due to CVDs, which represented 31% of all deaths, globally. Additionally, Increases prevalence in the rare diseases is another fuelling factor for the growth of global market. Moreover, favorable government policies on the use of orphan drugs which is further propelling factor for the growth of the target market. However, high cost of pre patient restrain the growth of the global market. Furthermore, limited patient pool for the product marketing and clinical trials hampers growth of the target market. Nevertheless, increase in the government or FDA approval for the orphan drugs can create an opportunity for the growth of global orphan drugs market.

Segmentation:

The global orphan drugs market is segmented based on drug type, disease, disease type, phase, and region.

On the basis of drug type, the global orphan drugs market is segmented into biological and non- biological. Biological drug type segment is expected to register the highest market growth during the forecast period. On the basis of top selling drugs, the target market is segmented into revlimid, rituxan, copaxone, opdivo, keytruda, imbruvica, avonex, sensipar, soliris, and other top selling drugs. Based on disease type, the global market is classified into oncology, hematology, neurology, cardiovascular, and other disease types. Oncology is the main disease segment which generates the largest revenue each year over the forecast period. On the basis of phase segment, the target market divided into phase I, phase II, phase III, and phase IV.

Based on region the global orphan drugs market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The global market in North America region is seen to have a matured growth since this market correlates with the increasing growth rate of orphan disease. In North America region is the dominating region due to the U.S. is the largest share of market holder of the orphan drugs. In U.S., FDA gives approval to the specific indication, tax credits for orphan drugs.

Key Players:

The key players operating the global orphan drugs market involves AbbVie Inc., Celgene Corporation, Biogen, Teva Pharmaceutical Industries, F. Hoffmann-La Roche AG, Bristol-Myers Squibb Company, Alexion Pharmaceuticals, Amgen, Merck & Co. Inc., Jazz Pharmaceuticals Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the drug types in order to gain competitive edge in the target market.

Detailed Segmentation:

Global Orphan Drugs Market, By Drug Type:

  • Biological
  • Non- Biological

Global Orphan Drugs Market, By Top Selling Drugs:

  • Revlimid
  • Rituxan
  • Copaxone
  • Opdivo
  • Keytruda
  • Imbruvica
  • Avonex
  • Sensipar
  • Soliris
  • Other Top Selling Drugs

Global Orphan Drugs Market, By Disease Type:

  • Oncology
  • Hematology
  • Neurology
  • Cardiovascular
  • Other Disease Types

Global Orphan Drugs Market, By Phase Type:

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Global Orphan Drugs Market, By Region:

      • North America
        • North America Orphan Drugs Market, By Drug Type
        • North America Orphan Drugs Market, By Top Selling Drugs
        • North America Orphan Drugs Market, By Disease Type
        • North America Orphan Drugs Market, By  Phase Type
        • North America Orphan Drugs Market, By Country
          • U.S.
          • Canada
      • Europe
        • Europe Orphan Drugs Market, By Drug Type
        • Europe Orphan Drugs Market, By Top Selling Drugs
        • Europe Orphan Drugs Market, By Disease Type
        • Europe Orphan Drugs Market, By Phase Type
        • Europe Orphan Drugs Market, By Country
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
        • Asia Pacific Orphan Drugs Market, By Drug Type
        • Asia Pacific Orphan Drugs Market, By Top Selling Drugs
        • Asia Pacific Orphan Drugs Market, By Disease Type
        • Asia Pacific Orphan Drugs Market, By Phase Type
        • Asia Pacific Orphan Drugs Market, By Country
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific                                                                                                                                                                                          
      • Latin America
        • Latin America Orphan Drugs Market, By Drug Type
        • Latin America Orphan Drugs Market, By Top Selling Drugs
        • Latin America Orphan Drugs Market, By Disease Type
        • Latin America Orphan Drugs Market, By Phase Type
        • Latin America Orphan Drugs Market, By Country
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
        • Middle East & Africa Orphan Drugs Market, By Drug Type
        • Middle East & Africa Orphan Drugs Market, By Top Selling Drugs
        • Middle East & Africa Orphan Drugs Market, By Disease Type
        • Middle East & Africa Orphan Drugs Market, By Phase Type
        • Middle East & Africa Orphan Drugs Market, By Country
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Company Profile:

  • AbbVie Inc.*
        • Company Overview
        • Drug Type Portfolio
        • Key Highlights
        • Financial Performance
  • Celgene Corporation
  • Biogen
  • Teva Pharmaceutical Industries
  • F. Hoffmann-La Roche AG
  • Bristol-Myers Squibb Company
  • Alexion Pharmaceuticals
  • Amgen
  • Merck & Co. Inc.
  • Jazz Pharmaceuticals

 “*” marked represents similar segmentation in other categories in the respective section

Key Issues Addressed

  • What is the total revenue potential of the global the orphan drugs market?
  • How that market is expected to grow during the study period?
  • What are some of the major growth opportunities in the orphan drugs market?
  • Which companies are the major players in the orphan drugs market?

No data available what are you looking for? Kindly fill below form for your specific research requirement

 Can't read the image? click here to refresh.

Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    •  Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Industry Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for Orphan Drugs Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Drug Type
      • Market Snippet, By Top Selling Drugs
      • Market Snippet, By Disease Type
      • Market Snippet, By Phase
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global Orphan Drugs Market, By Drug Type, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Biological
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Non- Biological
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Global Orphan Drugs Market, By Top Selling Drugs, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Revlimid
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Rituxan
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Copaxone
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Opdivo
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Keytruda
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Imbruvica
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Avonex
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Sensipar
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Soliris
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Other Top Selling Drugs
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Global Orphan Drugs Market, By Disease Type, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Oncology
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Hematology
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Neurology
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Cardiovascular
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Other Disease Type
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  8. Global Orphan Drugs Market, By Phase, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Phase I
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Phase II
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Phase III
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Phase IV
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  9. Global Orphan Drugs Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Drug Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Top Selling Drugs, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Disease Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Phase, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Drug Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Top Selling Drugs, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Disease Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Phase, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Drug Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Top Selling Drugs, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Disease Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Phase, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Drug Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Top Selling Drugs, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Disease Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Phase, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Drug Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Top Selling Drugs, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Disease Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Phase, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  10. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  11. Company Profiles
      • AbbVie Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Celgene Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Biogen
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Teva Pharmaceutical Industries
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • F.Hoffmann-La Roche AG
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      •  Bristol-Myers Squibb Company
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Alexion Pharmaceuticals
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Amgen
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Merck & Co. Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Jazz Pharmaceuticals
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
  12. The Last Word
    • Future Impact
    • About Us
    • Contact

 

 

  • We at Prophecy Market Insights performs in-depth primary and secondary market research to identify market growth and restraining factors, opportunities, and trends, and to determine the key players in the target market, market size of the target market, leading products, leading applications in the target market, suppliers and distributors in the target market etc.
  • Primary Research – Prophecy Market Insights formulates a detailed discussion guide to perform primary research. In primary research collection of data is performed through telephonic interview, E-mail questionnaire’s, and in-depth discussion with industry experts, manufacturers, suppliers, distributors, and end-users. The primary research participant includes but not limited to CEO’s, Managers, Directors, VP’s, Suppliers, and CSO’s.
  • Secondary Research – Our research analyst performs in-depth secondary research and extensive data mining to collect market related information through various authentic data sources such as Government Portals, Annual Reports, Trade Publications, Clinical Trials Publications, Research Publications, Company Press Release, and some paid data sources.
  • In-house Data Analysis – After extensive data mining, we perform in-house market analysis by using various data tools, statistical methods, and data analysis tools to arrive on a conclusion and reduce the margin of error. We provide our overviews and market forecast for the target market after thoroughly understanding and analyzing of collected data, historic market trends, and research outputs.
  • Report Delivery – Prophecy Market Insights provide report in required electronic format (preferably in PDF format), as PDF format is easy to read and present.
How May I Help You ?

Facing difficulties to find research data that meet your requirement? We are here to assist you. Get in connect with our representative for your specific requirement.

Knowledge Center